TechnipFMC grants shares to EVP & CTO Rounce

Rounce Justin reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Rounce Justin reported acquisition or exercise transactions in this Form 4 filing.

TechnipFMC plc reported that EVP & Chief Technology Officer Justin Rounce received two equity awards in the form of Ordinary Shares. He was granted 10,268 restricted stock units that vest in three equal annual installments, and 188,864 performance stock units scheduled to vest on February 21, 2026 based on the company’s performance criteria.

Insider Trade Summary

Grant/Award: 199,132 shares

Grant/Award 2 txns

Insider Rounce Justin

Role EVP & Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	10,268	$0.00	$0.00
Grant/Award	Ordinary Shares	188,864	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 339,339 shares (Direct)

Footnotes (2)

1. F1. This grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, is subject to a three-year vesting schedule whereby one-third (1/3) of the shares will vest on each of the first, second, and third anniversaries of the date of grant subject to the employee's continued service on the applicable vesting date.
2. F2. Represents an award of performance stock units, which is scheduled to vest on February 21, 2026, in the form of Ordinary Shares based upon the Issuer's performance against certain performance criteria.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did TechnipFMC (FTI) report for Justin Rounce?

TechnipFMC reported that EVP & Chief Technology Officer Justin Rounce acquired two equity awards. He received 10,268 restricted stock units and 188,864 performance stock units, both at no cash purchase price, increasing his directly held Ordinary Shares, subject to vesting conditions.

How many TechnipFMC (FTI) shares were granted to Justin Rounce?

Justin Rounce was granted 10,268 restricted stock units and 188,864 performance stock units. Each unit represents a contingent right to receive one Ordinary Share, so together the awards cover 199,132 potential Ordinary Shares, subject to vesting schedules and performance criteria described in the grant terms.

What is the vesting schedule for Justin Rounce’s restricted stock units at TechnipFMC (FTI)?

The 10,268 restricted stock units vest over three years. One-third vests on each of the first, second, and third anniversaries of the grant date, and vesting requires Justin Rounce’s continued service with TechnipFMC on each applicable vesting date.

When do Justin Rounce’s performance stock units in TechnipFMC (FTI) vest?

The 188,864 performance stock units are scheduled to vest on February 21, 2026. Vesting occurs in Ordinary Shares and depends on TechnipFMC’s performance against specified performance criteria, making the final earned amount contingent on company results over the performance period.

Did Justin Rounce buy TechnipFMC (FTI) shares on the open market?

No, the filing describes equity awards, not open-market purchases. The shares are granted at a stated price of zero per share as restricted stock units and performance stock units, which may settle into Ordinary Shares only if the vesting and performance conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:29 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rounce Justin

(Last) (First) (Middle)

C/O TECHNIPFMC PLC

HADRIAN HOUSE, WINCOMBLEE ROAD

(Street)

NEWCASTLE UPON TYNE X0 NE6 3PL

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TechnipFMC plc [ FTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/16/2026		A		10,268(1)	A	$0	150,475	D
Ordinary Shares	02/16/2026		A		188,864(2)	A	$0	339,339	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, is subject to a three-year vesting schedule whereby one-third (1/3) of the shares will vest on each of the first, second, and third anniversaries of the date of grant subject to the employee's continued service on the applicable vesting date.

2. Represents an award of performance stock units, which is scheduled to vest on February 21, 2026, in the form of Ordinary Shares based upon the Issuer's performance against certain performance criteria.

Remarks:

	/s/ Lisa P. Wang, Attorney-In-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.